diphenylamine has been researched along with Metastase in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chernoff, J; Deyev, SM; Dubyk, C; Handorf, E; Lazar, AJ; Semenova, G; Stepanova, DS | 1 |
| Agiostratidou, G; Anzovino, A; Chandiramani, N; Cohen, HW; Hazan, RB; Hulit, J; Kim, S; McDaid, HM; Nagi, C; Norton, L; Phillips, GR; Qian, X; Suyama, K; Yao, J | 1 |
| Kamioka, Y; Kiyokawa, E; Kumagai, Y; Matsuda, M; Nakasyo, E; Naoki, H | 1 |
| Choi, HJ; Heo, J; Hsieh, WS; Hsu, C; Jeffers, M; Kappeler, C; Krissel, H; Lim, HY; Lin, CY; Park, JW; Poon, RT; Rajagopalan, P; Rau, KM; Tak, WY; Tay, MH; Yen, CJ; Yeo, W; Yoon, JH | 1 |
1 trial(s) available for diphenylamine and Metastase
| Article | Year |
|---|---|
A phase II study of the efficacy and safety of the combination therapy of the MEK inhibitor refametinib (BAY 86-9766) plus sorafenib for Asian patients with unresectable hepatocellular carcinoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Asian People; Biomarkers; Carcinoma, Hepatocellular; Diphenylamine; Female; Humans; Liver Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Niacinamide; Phenylurea Compounds; Sorafenib; Sulfonamides; Treatment Outcome | 2014 |
3 other study(ies) available for diphenylamine and Metastase
| Article | Year |
|---|---|
Targeting group I p21-activated kinases to control malignant peripheral nerve sheath tumor growth and metastasis.
Topics: Animals; Benzamides; Cell Line, Tumor; Diphenylamine; Female; Humans; Mice; Mice, SCID; Molecular Targeted Therapy; Neoplasm Metastasis; Nerve Sheath Neoplasms; p21-Activated Kinases; Protein Kinase Inhibitors; Random Allocation; Signal Transduction; Xenograft Model Antitumor Assays | 2017 |
N-cadherin/FGFR promotes metastasis through epithelial-to-mesenchymal transition and stem/progenitor cell-like properties.
Topics: Aldehyde Dehydrogenase; Animals; Benzamides; Breast Neoplasms; Cadherins; Cell Movement; Cell Proliferation; Cyclin D1; Diphenylamine; Epithelial-Mesenchymal Transition; Extracellular Signal-Regulated MAP Kinases; Female; Humans; Lung Neoplasms; MAP Kinase Kinase 1; Mice; Mice, Transgenic; Neoplasm Invasiveness; Neoplasm Metastasis; Phosphorylation; Proto-Oncogene Proteins c-akt; Pyrimidines; Receptor, ErbB-2; Receptors, Fibroblast Growth Factor; RNA Interference; RNA, Small Interfering; Signal Transduction; Snail Family Transcription Factors; Spheroids, Cellular; Stem Cells; Transcription Factors; Tumor Cells, Cultured | 2014 |
Heterogeneity in ERK activity as visualized by in vivo FRET imaging of mammary tumor cells developed in MMTV-Neu mice.
Topics: Animals; Antineoplastic Agents; Benzamides; Computer Systems; Diphenylamine; Extracellular Signal-Regulated MAP Kinases; Female; Fluorescence Resonance Energy Transfer; Genes, erbB-2; Mammary Neoplasms, Experimental; Mammary Tumor Virus, Mouse; Mice; Mice, Transgenic; Molecular Imaging; Neoplasm Metastasis; Protein Kinase Inhibitors | 2015 |